Randomized pilot trial of a synbiotic dietary supplement in chronic HIV-1 infection

BMC Complementary and Alternative Medicine

Volumn 12, Issue , 2012, Pages

  Schunter, Marco ^a   Chu, Hiutung ^a   Hayes, Timothy L ^a   McConnell, Delandy ^a   Crawford, Sean S ^a   Luciw, Paul A ^a   Bengmark, Stig ^b   Asmuth, David M ^a   Brown, Jennifer ^a   Bevins, Charles L ^a   Shacklett, Barbara L ^a   Critchfield, J W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Combined antiretroviral therapy (CART); Complementary therapy.; Highly active antiretroviral therapy (HAART); Human immunodeficiency virus 1 (HIV 1); Immune activation; Microbial translocation; Prebiotics; Probiotics; Synbiotics

Indexed keywords

C REACTIVE PROTEIN; CD14 ANTIGEN; CD38 ANTIGEN; DNA 16S; HLA DR ANTIGEN; PLACEBO; PROBIOTIC AGENT; PROGRAMMED DEATH 1 RECEPTOR; SYNBIOTIC 2000; UNCLASSIFIED DRUG;

ADULT; ANTIGEN EXPRESSION; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIUM DETECTION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY FIBER; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG FORMULATION; FECES ANALYSIS; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; LACTOBACILLUS PLANTARUM; MONOCYTE; NONHUMAN; PARALLEL DESIGN; PEDIOCOCCUS; PEDIOCOCCUS PENTOSACEUS; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL; T LYMPHOCYTE ACTIVATION;

EID: 84863002605     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/1472-6882-12-84     Document Type: Article

References (48)

1. Brenchley JM, Douek DC. HIV infection and the gastrointestinal immune system. Mucosal Immunol 2008, 1:23-30. 10.1038/mi.2007.1, 2777614, 19079157.
2. Estes J, Baker JV, Brenchley JM, Khoruts A, Barthold JL, Bantle A, Reilly CS, Beilman GJ, George ME, Douek DC, et al. Collagen deposition limits immune reconstitution in the gut. J Infect Dis 2008, 198:456-464. 10.1086/590112, 2683984, 18598193.
3. Batman PA, Miller AR, Sedgwick PM, Griffin GE. Autonomic denervation in jejunal mucosa of homosexual men infected with HIV. AIDS 1991, 5:1247-1252. 10.1097/00002030-199110000-00015, 1786151.
4. Griffin GE, Miller A, Batman P, Forster SM, Pinching AJ, Harris JR, Mathan MM. Damage to jejunal intrinsic autonomic nerves in HIV infection. AIDS 1988, 2:379-382. 10.1097/00002030-198810000-00008, 3146267.
5. Mathan MM, Griffin GE, Miller A, Batman P, Forster S, Pinching A, Harris W. Ultrastructure of the jejunal mucosa in human immunodeficiency virus infection. J Pathol 1990, 161:119-127. 10.1002/path.1711610206, 2380806.
6. Blanshard C, Ellis DS, Tovey G, Gazzard BG. Electron microscopy of rectal biopsies in HIV-positive individuals. J Pathol 1993, 169:79-87. 10.1002/path.1711690113, 8433218.
7. Li Q, Estes JD, Duan L, Jessurun J, Pambuccian S, Forster C, Wietgrefe S, Zupancic M, Schacker T, Reilly C, et al. Simian immunodeficiency virus-induced intestinal cell apoptosis is the underlying mechanism of the regenerative enteropathy of early infection. J Infect Dis 2008, 197:420-429. 10.1086/525046, 18199035.
8. Nazli A, Chan O, Dobson-Belaire WN, Ouellet M, Tremblay MJ, Gray-Owen SD, Arsenault AL, Kaushic C. Exposure to HIV-1 directly impairs mucosal epithelial barrier integrity allowing microbial translocation. PLoS Pathog 2010, 6:e1000852. 10.1371/journal.ppat.1000852, 2851733, 20386714.
9. Sankaran S, George MD, Reay E, Guadalupe M, Flamm J, Prindiville T, Dandekar S. Rapid onset of intestinal epithelial barrier dysfunction in primary human immunodeficiency virus infection is driven by an imbalance between immune response and mucosal repair and regeneration. J Virol 2008, 82:538-545. 10.1128/JVI.01449-07, 2224350, 17959677.
10. Gori A, Tincati C, Rizzardini G, Torti C, Quirino T, Haarman M, Ben Amor K, van Schaik J, Vriesema A, Knol J, et al. Early impairment of gut function and gut flora supporting a role for alteration of gastrointestinal mucosa in human immunodeficiency virus pathogenesis. J Clin Microbiol 2008, 46:757-758. 10.1128/JCM.01729-07, 2238068, 18094140.
11. Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, Rao S, Kazzaz Z, Bornstein E, Lambotte O, Altmann D, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 2006, 12:1365-1371.
12. Keating J, Bjarnason I, Somasundaram S, Macpherson A, Francis N, Price AB, Sharpstone D, Smithson J, Menzies IS, Gazzard BG. Intestinal absorptive capacity, intestinal permeability and jejunal histology in HIV and their relation to diarrhoea. Gut 1995, 37:623-629. 10.1136/gut.37.5.623, 1382865, 8549936.
13. Lim SG, Menzies IS, Lee CA, Johnson MA, Pounder RE. Intestinal permeability and function in patients infected with human immunodeficiency virus. A comparison with coeliac disease. Scand J Gastroenterol 1993, 28:573-580. 10.3109/00365529309096090, 8362208.
14. Pernet P, Vittecoq D, Kodjo A, Randrianarisolo MH, Dumitrescu L, Blondon H, Bergmann JF, Giboudeau J, Aussel C. Intestinal absorption and permeability in human immunodeficiency virus-infected patients. Scand J Gastroenterol 1999, 34:29-34.
15. Jiang W, Lederman MM, Hunt P, Sieg SF, Haley K, Rodriguez B, Landay A, Martin J, Sinclair E, Asher AI, et al. Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection. J Infect Dis 2009, 199:1177-1185. 10.1086/597476, 2728622, 19265479.
16. Estes JD, Harris LD, Klatt NR, Tabb B, Pittaluga S, Paiardini M, Barclay GR, Smedley J, Pung R, Oliveira KM, et al. Damaged intestinal epithelial integrity linked to microbial translocation in pathogenic simian immunodeficiency virus infections. PLoS Pathog 2010, 6:e1001052. 10.1371/journal.ppat.1001052, 2924359, 20808901.
17. Giorgi JV, Hultin LE, McKeating JA, Johnson TD, Owens B, Jacobson LP, Shih R, Lewis J, Wiley DJ, Phair JP, et al. Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J Infect Dis 1999, 179:859-870. 10.1086/314660, 10068581.
18. Marchetti G, Bellistri GM, Borghi E, Tincati C, Ferramosca S, La Francesca M, Morace G, Gori A, Monforte AD. Microbial translocation is associated with sustained failure in CD4+ T-cell reconstitution in HIV-infected patients on long-term highly active antiretroviral therapy. AIDS 2008, 22:2035-2038. 10.1097/QAD.0b013e3283112d29, 18784466.
19. McFarland LV. Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease. Am J Gastroenterol 2006, 101:812-822. 10.1111/j.1572-0241.2006.00465.x, 16635227.
20. Gibson GR, Roberfroid MB. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr 1995, 125:1401-1412.
21. Karczewski J, Troost FJ, Konings I, Dekker J, Kleerebezem M, Brummer RJ, Wells JM. Regulation of human epithelial tight junction proteins by Lactobacillus plantarum in vivo and protective effects on the epithelial barrier. Am J Physiol Gastrointest Liver Physiol 2010, 298:G851-G859. 10.1152/ajpgi.00327.2009, 20224007.
22. Mennigen R, Nolte K, Rijcken E, Utech M, Loeffler B, Senninger N, Bruewer M. Probiotic mixture VSL#3 protects the epithelial barrier by maintaining tight junction protein expression and preventing apoptosis in a murine model of colitis. Am J Physiol Gastrointest Liver Physiol 2009, 296:G1140-G1149. 10.1152/ajpgi.90534.2008, 19221015.
23. Qin H, Zhang Z, Hang X, Jiang Y. L. plantarum prevents enteroinvasive Escherichia coli-induced tight junction proteins changes in intestinal epithelial cells. BMC Microbiol 2009, 9:63. 10.1186/1471-2180-9-63, 2674056, 19331693.
24. Zyrek AA, Cichon C, Helms S, Enders C, Sonnenborn U, Schmidt MA. Molecular mechanisms underlying the probiotic effects of Escherichia coli Nissle 1917 involve ZO-2 and PKCzeta redistribution resulting in tight junction and epithelial barrier repair. Cell Microbiol 2007, 9:804-816. 10.1111/j.1462-5822.2006.00836.x, 17087734.
25. Caballero-Franco C, Keller K, De Simone C, Chadee K. The VSL#3 probiotic formula induces mucin gene expression and secretion in colonic epithelial cells. Am J Physiol Gastrointest Liver Physiol 2007, 292:G315-G322.
26. Mack DR, Michail S, Wei S, McDougall L, Hollingsworth MA. Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. Am J Physiol 1999, 276:941-950.
27. Mattar AF, Teitelbaum DH, Drongowski RA, Yongyi F, Harmon CM, Coran AG. Probiotics up-regulate MUC-2 mucin gene expression in a Caco-2 cell-culture model. Pediatr Surg Int 2002, 18:586-590. 10.1007/s00383-002-0855-7, 12471471.
28. Altenhoefer A, Oswald S, Sonnenborn U, Enders C, Schulze J, Hacker J, Oelschlaeger TA. The probiotic Escherichia coli strain Nissle 1917 interferes with invasion of human intestinal epithelial cells by different enteroinvasive bacterial pathogens. FEMS Immunol Med Microbiol 2004, 40:223-229. 10.1016/S0928-8244(03)00368-7, 15039098.
29. Resta-Lenert S, Barrett KE. Live probiotics protect intestinal epithelial cells from the effects of infection with enteroinvasive Escherichia coli (EIEC). Gut 2003, 52:988-997. 10.1136/gut.52.7.988, 1773702, 12801956.
30. Gill HS, Shu Q, Lin H, Rutherfurd KJ, Cross ML. Protection against translocating Salmonella typhimurium infection in mice by feeding the immuno-enhancing probiotic Lactobacillus rhamnosus strain HN001. Med Microbiol Immunol 2001, 190:97-104.
31. Liu Q, Duan ZP, Ha DK, Bengmark S, Kurtovic J, Riordan SM. Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis. Hepatology 2004, 39:1441-1449. 10.1002/hep.20194, 15122774.
32. Ruan X, Shi H, Xia G, Xiao Y, Dong J, Ming F, Wang S. Encapsulated Bifidobacteria reduced bacterial translocation in rats following hemorrhagic shock and resuscitation. Nutrition 2007, 23:754-761. 10.1016/j.nut.2007.07.002, 17706400.
33. van Minnen LP, Timmerman HM, Lutgendorff F, Verheem A, Harmsen W, Konstantinov SR, Smidt H, Visser MR, Rijkers GT, Gooszen HG, Akkermans LM. Modification of intestinal flora with multispecies probiotics reduces bacterial translocation and improves clinical course in a rat model of acute pancreatitis. Surgery 2007, 141:470-480. 10.1016/j.surg.2006.10.007, 17383524.
34. Zareie M, Johnson-Henry K, Jury J, Yang PC, Ngan BY, McKay DM, Soderholm JD, Perdue MH, Sherman PM. Probiotics prevent bacterial translocation and improve intestinal barrier function in rats following chronic psychological stress. Gut 2006, 55:1553-1560. 10.1136/gut.2005.080739, 1860130, 16638791.
35. Kotzampassi K, Giamarellos-Bourboulis EJ, Voudouris A, Kazamias P, Eleftheriadis E. Benefits of a synbiotic formula (Synbiotic 2000Forte) in critically Ill trauma patients: early results of a randomized controlled trial. World J Surg 2006, 30:1848-1855. 10.1007/s00268-005-0653-1, 16983476.
36. Rayes N, Seehofer D, Theruvath T, Mogl M, Langrehr JM, Nussler NC, Bengmark S, Neuhaus P. Effect of enteral nutrition and synbiotics on bacterial infection rates after pylorus-preserving pancreatoduodenectomy: a randomized, double-blind trial. Ann Surg 2007, 246:36-41. 10.1097/01.sla.0000259442.78947.19, 1899208, 17592288.
37. Rayes N, Seehofer D, Theruvath T, Schiller RA, Langrehr JM, Jonas S, Bengmark S, Neuhaus P. Supply of pre- and probiotics reduces bacterial infection rates after liver transplantation-a randomized, double-blind trial. Am J Transplant 2005, 5:125-130. 10.1111/j.1600-6143.2004.00649.x, 15636620.
38. Wang Y, Qian PY. Conservative fragments in bacterial 16S rRNA genes and primer design for 16S ribosomal DNA amplicons in metagenomic studies. PLoS One 2009, 4:e7401. 10.1371/journal.pone.0007401, 2754607, 19816594.
39. Liu Z, Lozupone C, Hamady M, Bushman FD, Knight R. Short pyrosequencing reads suffice for accurate microbial community analysis. Nucleic Acids Res 2007, 35:e120. 10.1093/nar/gkm541, 2094085, 17881377.
40. Lau B, Sharrett AR, Kingsley LA, Post W, Palella FJ, Visscher B, Gange SJ. C-reactive protein is a marker for human immunodeficiency virus disease progression. Arch Intern Med 2006, 166:64-70. 10.1001/archinte.166.1.64, 16401812.
41. Lien E, Aukrust P, Sundan A, Muller F, Froland SS, Espevik T. Elevated levels of serum-soluble CD14 in human immunodeficiency virus type 1 (HIV-1) infection: correlation to disease progression and clinical events. Blood 1998, 92:2084-2092.
42. Hummelen R, Vos AP, van't Land B, van Norren K, Reid G. Altered host-microbe interaction in HIV: a target for intervention with pro- and prebiotics. Int Rev Immunol 2010, 29:485-513. 10.3109/08830185.2010.505310, 20839912.
43. Trois L, Cardoso EM, Miura E. Use of probiotics in HIV-infected children: a randomized double-blind controlled study. J Trop Pediatr 2008, 54:19-24.
44. Irvine SL, Hummelen R, Hekmat S, Looman CW, Habbema JD, Reid G. Probiotic yogurt consumption is associated with an increase of CD4 count among people living with HIV/AIDS. J Clin Gastroenterol 2010, 44:e201-e205. 10.1097/MCG.0b013e3181d8fba8, 20463586.
45. Anukam KC, Osazuwa EO, Osadolor HB, Bruce AW, Reid G. Yogurt containing probiotic Lactobacillus rhamnosus GR-1 and L. reuteri RC-14 helps resolve moderate diarrhea and increases CD4 count in HIV/AIDS patients. J Clin Gastroenterol 2008, 42:239-243.
46. Hummelen R, Changalucha J, Butamanya NL, Koyama TE, Cook A, Habbema JD, Reid G. Effect of 25 weeks probiotic supplementation on immune function of HIV patients. Gut Microbes 2011, 2:80-85. 10.4161/gmic.2.2.15787, 21637031.
47. Gori A, Rizzardini G, Van't Land B, Amor KB, van Schaik J, Torti C, Quirino T, Tincati C, Bandera A, Knol J, et al. Specific prebiotics modulate gut microbiota and immune activation in HAART-naive HIV-infected adults: results of the "COPA" pilot randomized trial. Mucosal Immunol 2011, 4:554-563. 10.1038/mi.2011.15, 3158294, 21525866.
48. Almeida M, Cordero M, Almeida J, Orfao A. Relationship between CD38 expression on peripheral blood T-cells and monocytes, and response to antiretroviral therapy: a one-year longitudinal study of a cohort of chronically infected ART-naive HIV-1+ patients. Cytometry B Clin Cytom 2007, 72:22-33.